Azenta(US:AZTA) Financial Modeling Prep·2025-11-21 02:00Core Insights - Azenta, Inc. operates in the life sciences sector, focusing on sample exploration and management solutions, and was rebranded from Brooks Automation in December 2021 [1] - The company has two main segments: Life Sciences Products and Life Sciences Services, serving clients such as pharmaceutical and biotechnology companies, biorepositories, and research institutes [1] Financial Performance - The financial outlook for Azenta is positive, with a stable consensus price target of $38, while Evercore ISI has set a more optimistic target of $62 [2][3] - Azenta reported a 36% increase in third-quarter earnings per share (EPS), indicating strong operational performance [2][3] Future Expectations - The upcoming fiscal fourth quarter and full year 2025 earnings report, scheduled for November 21, 2025, is highly anticipated and will provide insights into the company's financial health and growth potential [4] - Leadership under President and CEO John Marotta and CFO Lawrence Lin positions Azenta favorably for continued success in the life sciences sector [4]